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ALTH OU GH airway inflammation and airway hyper-
reactivity are observed after allergen inhalation both
in allergic humans and animals, little is known about
the mechanisms by which inflammatory cells can
contribute to allergen-induced airway hyperreactiv-
ity. To understand how inflammatory cell infiltration
can contribute to airway hyperreactivity, the location
of these cells within the airways may be crucial.
Using a guinea pig model of acute allergic asthma,
we investigated the inflammatory cell infiltration in
different airway compartments at 6 and 24 h (i.e. after
the early and the late asthmatic reaction, respec-
tively) after allergen or saline challenge in relation to
changes in airway reactivity (AR) to histamine.
At 6 h after allergen challenge, a threefold (p <  0.01)
increase in the AR to histamine was observed. At 24 h
after challenge, the AR to histamine was lower, but
still significantly enhanced (1.6-fold, p <  0.05).
Adventitial eosinophil and neutrophil numbers in
both bronchi and bronchioli were significantly
increased at 6 h post-allergen provocation as com-
pared with saline (p <  0.01 for all), while there was a
strong tendency to enhanced eosinophils in the
bronchial submucosa at this time point (p = 0.08). At
24 h after allergen challenge, the eosinophilic and
neutrophilic cell infiltration was reduced. CD3+ T
lymphocytes were increased in the adventitial com-
partment of the large airways (p <  0.05) and in the
parenchyma (p <  0.05) at 24 h post-allergen, while
numbers of CD8+ cells did not differ from saline
treatment at any time point post-provocation.
The results indicate that, after allergen provoca-
tion, inflammatory cell numbers in the airways
are mainly elevated in the adventitial compartment.
The adventitial inflammation could be important
for the development of allergen-induced airway
hyperreactivity.
Key words: Eosinophils, Neutrophils, Lymphocytes, Sub-
mucosa, Adventitia, Parenchyma, Allergen-challenge, Airway
hyperreactivity, Guinea pigs
Introduction
Allergic asthma in man is clinically characterized by
bronchoconstriction in response to inhaled aero-
allergens, resulting in an early asthmatic reaction
(EAR) that is often followed by a late asthmatic
reaction (LAR). The EAR is thought to be primarily
caused by an immunoglobulin (Ig)E-mediated release
of mast cell mediators, while the LAR is associated
with the recruitment and activation of inflammatory
cells in the lung, including eosinophils, neutrophils
and lymphocytes.1– 4
Another important feature of allergic asthma is the
development of increased reactivity of the airways to
non-specific stimuli following allergen exposure,
referred to as airway hyperreactivity (AHR). Allergen-
induced AHR has been observed in patients with a
dual asthmatic reaction, and may already be present
before the onset of the LAR.5 –8 It is generally thought
that inflammatory cell influx in the airways is
involved in the development of AHR. However, a close
relationship between the number of inflammatory
cells in the airway lumen or mucosa and chronic AHR
has not invariably been found, which may possibly be
due to airway remodeling after prolonged
inflammation. 9 –11
Although information from biopsy studies is avail-
able about inflammation in the airway wall of
asthmatics, little is known about the distribution of
inflammatory cells throughout the entire airway
circumference and lung tissue of these patients.
Detailed knowledge about this distribution may be
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pivotal to understanding the role of inflammatory
cells in the development of AHR. Techniques to assess
airway inflammatory cell distribution in relation to
AHR in asthmatic patients are limited: biopsy samples
can only be collected from superficial layers of larger
proximal airways, which provide no information
about deeper peribronchial areas nor about more
distal smaller airways. In addition, cells obtained from
bronchoalveolar lavage (BAL) and sputum induction
represent primarily luminal inflammation. Detailed
histopathologic studies of the airways from patients
with fatal and non-fatal asthma with respect to
inflammatory cell distribution within and along the
airways have been performed,12 –17 but cannot be
quantitatively related with AHR.
The aim of the present study was to investigate the
distribution of the inflammatory infiltrate both within
the airway wall (i.e. the adventitia and submucosa)
and between the central and peripheral airways and
the parenchyma in relation to AHR after the allergen-
induced EAR and LAR. To this purpose, we used a
guinea pig model of allergic asthma with great
qualitative and quantitative similarities in allergen-
induced EAR, LAR and AHR after both reactions, and




Specified pathogen-free tri-colored bastard male
guinea pigs (Charles River; SAVO, Kiszlegg, Germany)
weighing 400–500 g were actively sensitized to oval-
bumin as described previously.19 To obtain a shift to
IgE class antibodies, an allergen solution containing
100 m g of ovalbumin and 100 mg of Al(OH)3 per ml
saline was used. The allergen solution was gently
rotated for 60 min to obtain an alu-gel, and 0.5 ml was
injected intraperitoneally, while another 0.5 ml was
divided over seven intracutaneous injection sites in
the proximity of lymph nodes in the paws, lumbar
regions and neck. Animals were operated on 3 weeks
after sensitization and used experimentally 4–8 weeks
after sensitization. The animals were housed in
individual cages in climate-controlled animal quarters,
and were given water and food ad libitum. All
protocols described were approved by the University
of Groningen Animal Ethical Committee.
Measurement of airway function
Airway function was assessed by measuring pleural
pressure (Ppl) as described previously.
20 In short, a
small saline-filled latex balloon connected to a saline-
filled canula was surgically implanted in the thoracic
cavity. The free end of the canula was subcutaneously
driven to the neck of the guinea pigs, where it was
exposed and attached permanently. The canula was
connected to a pressure transducer (Ohmeda DTX™;
SpectraMed, Bilthoven, The Netherlands) using an
external saline-filled canula. Ppl (cmH2O) was meas-
ured continuously using an on-line computer system.
We have previously shown that changes in Ppl are
linearly correlated to changes in airway resistance and
hence can be used as a sensitive index for allergic and
non-allergic bronchoconstriction.20 In this way, air-
way function can be monitored repeatedly and
continuously for prolonged periods of time, while the
animals are unaware of the measurements being
taken.
Provocation procedures
Ovalbumin and histamine provocations were per-
formed by inhalation of aerosolized solutions, pro-
duced by a DeVilbiss nebulizer (type 646; DeVilbiss,
Somerset, PA, USA), with an airflow of 8 l/min
resulting in an output of 0.33 ml/min. Provocations
were carried out in a specially designed perspex cage
(internal volume, 9 l) in which the guinea pigs could
move freely.
Before the start of the experiment, the animals
were habituated to the experimental conditions and
the provocation procedures on two sequential days at
least 1 week after surgery, when preoperative weight
was restored. On the first day, the animals were
placed in the provocation cage unconnected to the
pressure transducer. After an adaptation period of at
least 30 min, three consecutive provocations with
saline were performed, each provocation lasting
3 min and separated by a 7 min interval. The next day,
this procedure was repeated with the animals con-
nected to the measurement system
During the experimental protocol following the
habituation procedure, all provocations were pre-
ceded by a 30 min adaptation period and followed by
two consecutive control provocations with saline
(3 min) as already described. A baseline Ppl value was
calculated by averaging the Ppl values from the last
20 min of the adaptation period.
To assess the airway reactivity for histamine,
histamine provocations were started with a solution
containing 25 m g/ml of histamine in saline, followed
by increasing dosage steps of 25 m g/ml. Histamine
provocations lasted 3 min, separated by 7 min inter-
vals. Animals were challenged until Ppl was increased
by more than 100% above baseline, for at least three
consecutive minutes. Ppl returned to baseline value
within 15 min after the last histamine provocation.
The airway reactivity (AR) to histamine was expressed
as the concentration causing a 100% increase in Ppl
(PC100), which was calculated by linear intrapolation
of the concentration-Ppl response curve. Changes in
AR towards histamine were expressed as the ratio
PC100 pre/post allergen challenge.
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Ovalbumin provocations were performed by inhala-
tion of increasing concentrations of 1.0, 3.0 and
5.0 mg/ml of ovalbumin in saline for 3 min each,
separated by 7 min intervals. Allergen inhalations
were discontinued when an increase in Ppl of 100% or
more was observed. Using these conditions, none of
the animals developed anaphylactic shock after aller-
gen provocation. For the quantitative assessment of
the EAR and LAR, airway function was continuously
measured up to 24 h after allergen challenge. The
magnitudes of the allergen-induced EAR and LAR
were expressed as the area under the Ppl time-
response curve (AUC) between 0 and 6 h after
allergen provocation for the EAR, and between 8 and
24 h after provocation for the LAR. Ppl was expressed
as the percentage change from baseline, and AUC was
calculated by trapezoid integration over discrete
(5 min) time periods. Based on saline control provoca-
tions, threshold values of AUC (mean + 2 SD; 99%
confidence interval) were defined as 1185% ´ 5 min
for a positive early response and 2790% ´ 5 min for a
positive late response, respectively.18
Histamine PC100 values were assessed 24 h before,
and 6 h (after the EAR) and 24 h (after the LAR) after
ovalbumin provocation. Inhalations with saline
instead of ovalbumin served as controls. For tissue
sampling, animals were terminated at 6.5 h (group 1)
or at 24.5 h (group 2) after ovalbumin or saline
provocation.
Tissue processing
Guinea pigs were killed by cervical dislocation, after
which the lungs were immediately resected and kept
on ice in a petri dish during further processing.
Additionally, the spleen was removed for qualitative
assessment of antibody specificity. The superior and
median lobes of the right lung and the spleen were
snap frozen at –80°C in isopentane, and tissue was
stored at –80°C. Frozen sections were cut at a
thickness of 4 m m and stored, wrapped in aluminium
foil, at –20°C until use (within 2 weeks).
Inflammatory cell characterization
Inflammatory cells were identified using histochem-
ical and immunohistological techniques. Eosinophils
were identified using hematoxylin–eosin staining.
Neutrophils were identified by a combination of
morphologic criteria and tissue non-specific alkaline
phosphatase enzyme histochemistry, as described
previously.21
Infiltration of T cells in the lung was analyzed by
immunohistological techniques using a rabbit anti-
human CD3 polyclonal antibody (Dakopatts Ltd, High
Wycombe, UK) as a pan T-cell antibody, and the
murine monoclonal CT6 as a CD8+ T-cell antibody22
(generously provided by Prof. R.J. Scheper, Free
University of Amsterdam). In brief, frozen sections
were fixed at room temperature (RT) for 10 min in
100% acetone and washed for 5 min in phosphate-
buffered saline (PBS) (pH 7.4). To prevent non-
specific staining, the slides were incubated for 30 min
with 10% normal goat or normal rabbit serum,
respectively, diluted in PBS. Then, the sections were
incubated for 1 h at RT with the primary antibody
diluted (1:100 and 1:5000, respectively) in 1% bovine
serum albumin in PBS. After rinsing three times with
PBS for 5 min, endogenous peroxidase activity was
blocked by incubating the slides in 0.075% hydrogen
peroxide in PBS for 30 min. Following three washes
with PBS, the slides were incubated for 30 min with
peroxidase-conjugated secondary antibodies (Dako-
patts, Glosstrup, Denmark), diluted in 2% normal
guinea pig serum in PBS. A peroxidase-conjugated
goat-anti-rabbit IgG antibody (dilution 1:100) was
used for the detection of the CD3 polyclonal anti-
bodies, and a peroxidase-conjugated rabbit-anti-
mouse IgG (dilution 1:50) was used for the detection
of the CT6 monoclonal antibodies. Next, the sections
were washed in PBS and the peroxidase activity was
developed in a freshly prepared solution of 3-amino-
9-ethylcarbazol, containing 0.03% hydrogen peroxide
for 10 min. Counterstaining was performed using
Mayer’s hematoxylin. Antibody specificity was
checked by incubating adjacent lung sections with
non-relevant antibodies. Guinea pig spleen tissue
served as a positive control for specificity.
Cell quantification analysis
Using a light microscope (Olympus BH-2, Paes,
Zoeterwoude, The Netherlands), positively stained
cells were enumerated in three anatomical areas as
indicated in Fig. 1. The numbers of eosinophils,
neutrophils, total T cells and CD8+ T cells were
counted employing an eyepiece graticule comprising
100 squares of known area. The number of positive
cells present in the submucosa was expressed as cells
per millimeter of basement membrane. The length of
the basement membrane was estimated using the
formula derived from Buffons needle problem: Ba =
[( p /2)/IL] * d,
23 where Ba is the length of the boundary
(mm), IL is the number of intersections formed by the
boundary with the parallel lines of the grid, and d is the
distance between two parallel grid lines (mm).
Adventitial cell counts were carried out in the same
airways. Positive cells were expressed as cells per
millimeter of external smooth muscle perimeter. This
perimeter was also estimated using Buffons formula.
In the large airways, the adventitia was defined as the
area between the smooth muscle and the cartilage; in
the small airways, the adventitia was defined as a
50 m m border outside and directly adjacent to the
smooth muscle. In the parenchyma, positively stained
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cells were expressed as percent of total cell counts.
Per specimen, at least three large and three small
airways were enumerated and, in the parenchyma,
four random fields of 6.25 ´ 104 m m2 (the total area of
the graticule) were counted, and average values were
calculated per animal.
Statistical analysis
Statistical analysis on the magnitudes of the early and
the late asthmatic responses, and on the cell counts
between treatment groups, was performed using the
unpaired Mann–Whitney rank sum test. PC100 values
before and after allergen challenge were compared
using a one-way analysis of variance. When sig-
nificance was observed (p < 0.05), a complementary
Student–Newman–Keuls test was performed. For
comparison of AHR at different time points within
treatment groups, a Wilcoxon signed-rank test was
used.
For the correlation between AHR and inflammatory
cells, correlation coefficients and p values were
calculated using Spearman rank order correlation
analysis.
Results
Ovalbumin-induced early and late asthmatic
reactions
Figure 2 shows a typical example of a dual asthmatic
reaction, induced by ovalbumin provocation. The EAR
starts with a sharp increase in Ppl , which is maximal
within 20 min and lasts 2–4 h. The LAR starts at
approximately 8 h after allergen provocation, being
reversible within 24 h after the challenge. The airway
responses to allergen and saline control provocations
in animals terminated after the EAR and the LAR are
presented in Table 1.
Airway reactivity
Table 2 shows that an approximately threefold (p <
0.01) increase in AR to histamine was observed at 6 h
after allergen provocation in both groups of animals,
while a smaller but still significant AHR (1.57-fold
increase, p < 0.05) was observed at 24 h after allergen
challenge in the animals terminated after the LAR. No
change in airway reactivity was observed in saline-
challenged control animals.
Distribution of inflammatory cells in ovalbumin
and saline challenged animals
d Eosinophils. At 6 h after allergen provocation, a
significant fourfold increase in eosinophils was
observed in the adventitial layer of the bronchi (p
< 0.01; Fig. 3A), whereas in the adventitial layer
of the bronchioli an eightfold increase in eosino-
phil numbers was observed at the same time
point (p < 0.01; Fig. 3C). The adventitial eosino-
phil numbers were not significantly different
between large and small airways. Twenty-four
hours after allergen challenge, adventitial eosino-
phil numbers still tended to be elevated but no
longer reached statistical significance. In the sub-
mucosal layer of the bronchi, eosinophils tended
to be enhanced at 6 h after allergen exposure
compared with saline (p = 0.08; Fig. 3B), while at
24 h post-allergen submucosal eosinophil numbers
did not differ from controls. In addition, no
significant change was observed in the eosinophil
number of the bronchiolar submucosa (Fig. 3D).
Furthermore, in the parenchyma, no changes in
eosinophil numbers were observed either at 6 or
24 h after allergen (Fig. 3E). Cell numbers in
saline treated groups did not differ from one
another at any time point.
d Neutrophils. At 6 h after ovalbumin provocation,
neutrophil numbers were significantly elevated in
the adventitia of the bronchi (p < 0.01; Fig. 4A) as
F. Westerhof et al.
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FIG. 1. Anatomical areas studied in counting cellular infiltrates. In the parenchyma, random fields were counted, well away
from the airway. Adventitia, area between the smooth muscle layer and cartilage, or in the absence of cartilage, in a 50 m m layer
adjacent to the outer edge of the smooth muscle; submucosa, area between the basement membrane and the inner perimeter
of the smooth muscle layer.
well as in the bronchioli (p < 0.01; Fig. 4C). Twenty-
four hours after allergen exposure, some neu-
trophils were still present in the adventitia of the
large airways, but these numbers were not sig-
nificantly different from the saline-treated group
(Fig. 4A). Few neutrophils were observed in the
submucosal compartment of both large and small
airways, after allergen provocation (Fig. 4B,D,
respectively); however, no significant differences
were observed compared with saline. No neu-
trophils were present in the submucosal compart-
ment at any time point post-saline. Figure 4E shows
that neutrophil numbers were not significantly
elevated in the parenchyma at any time point post-
Inflammatory cell distribution and airway reactivity
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FIG. 2. Representative example of a dual asthmatic response after allergen provocation of an ovalbumin-sensitized guinea pig
(thick line). The thin line represents the result of a saline control challenge. Provocations were performed at 0 h.
Table 1. Airway responses of sensitized guinea pigs after saline inhalation or ovalbumin provocation
Group Inhalation AUC (% ´ 5 min)
EAR (n) LAR (n)
1 Saline 47 ± 203 (6) –
Ovalbumin 3553 ± 1156* (6) –
2 Saline 135 ± 862 (4) 420 ± 873 (4)
Ovalbumin 3071 ± 317† (6) 9038 ± 2545* (4)
Data are presented as area under the percent change in Ppl time-response curve (AUC) between 0 and 6 h after the allergen provocation for the
early asthmatic reaction (EAR) and between 8 h and 24 h after allergen provocation for the late asthmatic reaction (LAR). Results represent mean
values ± SEM of (n) animals. Group 1, guinea pigs terminated after the EAR; group 2, guinea pigs terminated after the LAR.
*p < 0.05, † p < 0.01 compared with saline inhalation, Mann–Whitney rank sum test.
allergen provocation as compared with saline-
treated animals.
d T-lymphocytes. CD3+ T-cell numbers showed no
quantitative changes at 6 h after allergen provoca-
tion in any of the compartments investigated in the
allergen-treated group as compared with controls
(Fig. 5A–E). At 24 h, however, CD3+ cells were
increased in both the adventitial layer of the large
airways (p < 0.05) and in the parenchyma (p <
0.05), as is shown in Fig. 5A,E, respectively. CD8+ T
cells showed no significant change at any time
point, after either ovalbumin or saline treatment
(not shown).
For all cell numbers, no significant differences
between large and small airways were observed.
No significant correlations between allergen-
induced cell infiltration in the different compartments
and AHR were observed, except for CD3+ cells in the
parenchyma at 24 h after ovalbumin (r = 0.89, p <
0.05).
Discussion
In a guinea pig model of allergic asthma, charac-
terized by allergen-induced EAR, LAR and AHR after
both reactions, we have explored the infiltration of
eosinophils, neutrophils, and T lymphocytes in the
submucosal and adventitial compartments of large
(cartilaginous) and small (non-cartilaginous) airways
at 6 and 24 h after allergen challenge. At 6 h after
challenge (i.e. after the EAR, but before the initiation
of the LAR; Fig. 2), a significant increase in eosinophil
and neutrophil numbers was observed in the adven-
titia of both large and small airways, while there was
a tendency to an increased eosinophil number in the
bronchial submucosa at this time point. The infiltra-
tion of eosinophils and neutrophils was reduced at
24 h after challenge, whereas a significant T-cell
infiltration was observed at this time point both in the
bronchial adventitia and in the parenchyma. The
allergen-induced increase in inflammatory cells was
associated with the development of AHR to histamine,
which, as shown previously in this model,18 was
maximal at 6 h after challenge and decreased, but still
significantly present, at 24 h after the provocation.
The temporal association between the degree of,
mainly adventitial, infiltration of eosinophils and
neutrophils and the degree of AHR to histamine at 6
and at 24 h after allergen challenge may indicate a
causal relationship between these events. However,
no significant correlations between infiltration of
these cells in any of the airway compartments and
AHR were observed. In addition, the enhanced T-cell
infiltration at 24 h after allergen challenge was not
significantly correlated with AHR. Apart from the
relatively low number of experiments, this may
indicate that other factors may be involved in the
development of allergen-induced AHR.
Likewise, in human asthmatics, no or only weak
correlations were found between AHR and inflamma-
tory cell numbers in BAL,9,24 – 27 induced spu-
tum,9,28 –31 and bronchial biopsies.9,32 –37 However,
inflammatory cells found in BAL or sputum represent
luminal instead of tissue inflammation, while endo-
bronchial biopsies only provide information about the
inflammatory response close to the surface of the
proximal airways (mucosa and submucosa), so a
possible relationship between AHR and inflammatory
cells in the airways could be easily overlooked using
these techniques.
Indeed, in previous studies using our guinea pig
model of allergic asthma, no significant correlation
was found between eosinophil and neutrophil num-
bers in BAL and AHR at 6 and 24 h after allergen
provocation.18 In this model of acute allergic asthma,
it was found that BAL eosinophils and neutrophils
were increased at 6 h after allergen provocation, and
even further increased at 24 h after allergen. In the
current study, it was observed that tissue eosinophils
and neutrophils peak at 6 h post-allergen and are
reduced at 24 h, supporting the idea that these cells
migrate from the tissue to the lumen. A similar
relationship between the time course of tissue and
F. Westerhof et al.
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Table 2. Airway reactivity to inhaled histamine of sensitized guinea pigs at 6 and 24 h after saline or ovalbumin inhalation
Group Inhalation Histamine PC100 pre/post inhalation
6 h (n) 24 h (n)
1 Saline 1.00 ± 0.03 (6) –
Ovalbumin 2.97 ± 0.34† (6) –
2 Saline 0.95 ± 0.06 (4) 1.00 ± 0.09 (4)
Ovalbumin 3.22 ± 0.51† (6) 1.57 ± 0.34*‡ (6)
Airway reactivity is expressed as the ratio of histamine provocation concentration causing 100% increase in pleural pressure (PC100 ) values
obtained at 24 h before, and 6 and 24 h after inhalation of saline or ovalbumin. Data represent mean values ± SEM of (n) animals. Group 1, guinea
pigs terminated after the early asthmatic reaction; group 2, guinea pigs terminated after the late asthmatic reaction.
*p < 0.05, † p < 0.01 compared with before treatment, one-way analysis of variance followed by the Student–Newman–Keuls test; ‡ p < 0.05
compared with 6 h post-ovalbumin, Wilcoxon signed rank test.
luminal infiltration of eosinophils was also found in
another guinea pig study38 and in asthmatic
patients.39
In addition to cellular infiltration in the different
airway compartments, the activation state of the
infiltrated cells may be an important determinant of
allergen-induced AHR. Thus, in biopsy studies in
patients, a positive correlation was found between
(activated) EG2+ eosinophils and AHR.34 In addition,
in mild asthmatics, a significant correlation was found
between the AHR to histamine and the concentration
of major basic protein (MBP) in the BAL.25 Accord-
ingly, in our guinea pig model, a possible relationship
between eosinophil activation and AHR was indicated
Inflammatory cell distribution and airway reactivity
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FIG. 3. Eosinophil numbers at 6 and 24 h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: * p < 0.01, Mann–Whitney rank sum test.
by the observation that levels of eosinophil per-
oxidase (EPO) in BAL fluid were already enhanced at
6 h after allergen challenge.40 Moreover, in the same
model, we have recently observed, in contrast to the
number of BAL eosinophils, that the activation state
of the cells (measured as EPO release) is higher at 6 h
after provocation than at 24 h after the challenge,
while a significant correlation was found between the
increased EPO release from the BAL cells and hista-
mine PC100 values at 6 h, but not at 24 h, after allergen
provocation (De Boer et al., unpublished results).
A third cause of possible dissociation between
inflammatory cell numbers and AHR in asthmatics
could be progressive airway remodeling, charac-
F. Westerhof et al.
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FIG. 4. Neutrophil numbers at 6 and 24 h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: *p < 0.01, Mann–Whitney rank sum test.
terized by thickening of the basement membrane,
subepithelial fibrosis, and hypertrophy and hyper-
plasia of airway smooth muscle, as occurs in chronic
asthma with persistent airway inflammation.41 In the
presence of these morphological changes, the pres-
ence of particular inflammatory cells in the airways is
not a prerequisite for (baseline) AHR.
Similar to the findings in the present study, the
occurrence of preferential adventitial rather than
submucosal eosinophilia after allergen challenge has
been reported previously in guinea pigs.42,43 How-
ever, in the study of Frew et al.,43 tissue eosinophilia
was observed between 17 and 48 h after the challenge
instead of after 6 h as observed in the present study.
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FIG. 5. Numbers of CD3+ cells at 6 and 24 h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: † p < 0.05, Mann–Whitney rank sum test.
Lapa e Silva et al.42 found no increase in sub-
mucosal eosinophil numbers at 2 and 24 h after
challenge, while adventitial eosinophils were elevated
at 24 h but not at 2 h after allergen challenge.
Different sensitization and provocation procedures
may account for the different kinetics of infiltration of
inflammatory cells in these models compared with
our model. Lapa e Silva et al.42 used an additional
booster for sensitization and challenged by the
intraperitoneal route instead of the inhalational route.
Frew et al.43 sensitized guinea pigs by inhalation,
challenged under protection of the H1 receptor
antagonist mepyramine and measured airway resist-
ance in a whole-body plethysmograph, while in our
model measurements were performed under freely
moving conditions, without antihistamine protection.
Very importantly, we have previously demonstrated
that mepyramine treatment may affect allergen-
induced asthmatic reactions, AHR and infiltration of
inflammatory cells.44
In lung tissue from patients with fatal asthma, as
well as lung specimens from asthmatics obtained at
surgery for lung cancer, adventitial eosinophilia has
also been described. In lung specimens obtained from
patients with asthma, Hamid et al.,45 found greater
numbers of eosinophils in the adventitia as compared
with the submucosa of airways with an internal
perimeter greater than 2 mm; however, activated
eosinophils seemed more numerous in the sub-
mucosa. In a recent study, Haley et al.46 reported a
difference in eosinophil distribution between large
and small airways in lung tissue from patients who
died from status asthmaticus. As in our study, the
eosinophilic infiltrate in the small airways was pre-
dominantly found in the adventitia. On the contrary,
large airways predominantly showed submucosal
eosinophilia, while both adventitial and submucosal
accumulation was found in our study. However, both
for the adventitial and the submucosal compartments,
the eosinophil infiltration was not significantly differ-
ent between large and small airways in our study. In
line with these results, Carroll et al.15 also found no
difference in eosinophil densities between large and
small airways in the inner wall area between the
basement membrane and the outer border of the
smooth muscle in patients dying from asthma. Since
studies performed on autopsy material of patients
represent cellular infiltration in a state of chronic
asthma, the relevance of the actual inflammatory cell
counts in this tissue in the contribution to AHR is
unknown.
Both human and guinea pig studies have indicated
that various mechanisms may be involved in eosino-
phil-induced AHR. Although eosinophilic infiltration
was mainly adventitial and epithelial damage was not
investigated in this study, it is well known that
eosinophilic granular cationic proteins may cause
epithelial damage, thereby causing enhanced airway
permeability and exposing the underlying sensory
nerves, which may lead to enhanced cholinergic and
excitatory non-adrenergic non-cholinergic reflex
activities.47– 49 Enhanced cholinergic reflex activity
after allergen challenge may also develop from a
dysfunction of autoinhibitory prejunctional muscari-
nic M2 receptors induced by eosinophil-derived
MBP.50– 52 In addition, it has recently been established
that eosinophilic polycations may be involved in a
deficiency of bronchodilating NO in the airways,
presumably by inhibition of cellular uptake of
L-arginine, the substrate for NO synthase.53– 57 Finally,
it is known that eosinophil-derived mediators like
LTC4 and reactive oxygen species may cause swelling
of the airway tissue by enhanced vascular permeabil-
ity.58 Since adventitial eosinophilia was most pro-
nounced, it is tempting to speculate that uncoupling
of the airway smooth muscle from the parenchyma
caused by eosinophil-induced outer wall swelling, as
proposed by Lambert et al.,59 is an important
determinant of the observed AHR.
In line with our results, several studies have
demonstrated increased neutrophil numbers in BAL
fluid from asthmatics and from guinea pigs after
allergen challenge.2,18,38,60 Moreover, there are
increasing indications that neutrophils may play a role
in acute severe asthma. Thus, enhanced infiltration
and/or activation of neutrophils has been demon-
strated in fatal asthma of sudden onset,61 status
asthmaticus,62 and during exacerbations of asthma.63
In addition, recent evidence from bronchial biopsies64
and induced sputum65 indicates that neutrophils may
also be involved in severe persistent asthma.
The role of neutrophils in the development of
allergen-induced AHR is presently unclear. Neutro-
phils have the capacity to generate enhanced levels of
superoxide anion (O2
– ) in patients with asthma,
which correlates with the airway reactivity to metha-
choline in these patients.66 In the presence of high
concentrations of inducible nitric oxide synthase
(iNOS)-derived nitric oxide in the inflamed airways,
O2
– may cause formation of the highly cytotoxic
oxidant peroxynitrite (ONOO– ), which has been
found to induce AHR.67 Moreover, ONOO– was
demonstrated to increase the release of MBP from
eosinophils in tracheal preparations,67 while neu-
trophils may also enhance eosinophilic LTC4 produc-
tion.68 In addition, neutrophils may enhance eosino-
phil recruitment and degranulation through secretion
of IL-8.65,69,70
Elevated CD3+ cells were found only at 24 h after
allergen provocation, both in the parenchyma and in
the bronchial adventitia. In addition, the number of
CD3+ cells in the parenchyma was correlated with
AHR. The observed rise in CD3+ cells was not
associated with a change in CD8+ cells. In the absence
of a specific antibody directed against guinea pig
CD4+ cells, the likely CD4+ character of these
F. Westerhof et al.
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CD3+CD8– cells, as in humans, remains to be estab-
lished. Elevated CD3+CD8– lymphocytes in guinea pig
bronchus, but not parenchyma, were also observed
by Frew et al.43 at 17 and 48 h after allergen. CD4+
Th2-lymphocytes could contribute to AHR by activa-
tion of eosinophils by the production of IL-5.71
In conclusion, our findings indicate that, in addi-
tion to (sub-)mucosal inflammation, inflammation in
the adventitia of both large and small airways could be
importantly involved in the development of AHR in a
guinea pig model of acute allergic asthma. Although
investigations of the entire human airway circum-
ference in relation to allergen-induced AHR are
hampered by technical limitations, this finding may
be of importance for asthmatic patients, and merits
further investigation.
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